D. Eric Mendelsohn Purchases 1,500 Shares of National Health Investors (NYSE:NHI) Stock

National Health Investors, Inc. (NYSE:NHI) CEO D. Eric Mendelsohn bought 1,500 shares of the business’s stock in a transaction on Friday, June 5th. The shares were acquired at an average cost of $68.84 per share, for a total transaction of $103,260.00. Following the transaction, the chief executive officer directly owned 133,316 shares in the company, valued at approximately $9,177,473.44. This trade represents a 1.14% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website.

National Health Investors Trading Up 3.0%

NYSE NHI opened at $70.35 on Friday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 8.20 and a current ratio of 8.20. The company has a market capitalization of $3.41 billion, a price-to-earnings ratio of 22.69, a price-to-earnings-growth ratio of 3.68 and a beta of 0.52. The company’s 50-day simple moving average is $78.33 and its two-hundred day simple moving average is $80.31. National Health Investors, Inc. has a one year low of $67.94 and a one year high of $91.38.

National Health Investors (NYSE:NHI) last posted its earnings results on Monday, May 4th. The real estate investment trust reported $0.82 EPS for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.39). The business had revenue of $115.13 million for the quarter, compared to analysts’ expectations of $70.22 million. National Health Investors had a net margin of 36.86% and a return on equity of 9.82%. The company’s revenue for the quarter was up 28.9% on a year-over-year basis. During the same period last year, the business posted $1.15 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Equities analysts forecast that National Health Investors, Inc. will post 5.07 EPS for the current fiscal year.

National Health Investors Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Tuesday, June 30th will be given a dividend of $0.92 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.68 dividend on an annualized basis and a yield of 5.2%. National Health Investors’s dividend payout ratio (DPR) is 118.71%.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on NHI. Truist Financial cut their price objective on shares of National Health Investors from $92.00 to $89.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Weiss Ratings reaffirmed a “buy (b)” rating on shares of National Health Investors in a research report on Friday, March 27th. Wells Fargo & Company cut their price objective on shares of National Health Investors from $84.00 to $79.00 and set an “equal weight” rating on the stock in a research report on Monday, June 1st. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $94.00 price objective on shares of National Health Investors in a research report on Wednesday, April 22nd. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $86.67.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of NHI. Norges Bank purchased a new position in shares of National Health Investors in the 4th quarter worth approximately $55,301,000. JPMorgan Chase & Co. grew its position in National Health Investors by 34.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,613,051 shares of the real estate investment trust’s stock worth $128,238,000 after purchasing an additional 409,559 shares during the last quarter. Freestone Grove Partners LP purchased a new stake in National Health Investors during the 4th quarter worth approximately $21,869,000. Adage Capital Partners GP L.L.C. purchased a new stake in National Health Investors during the 4th quarter worth approximately $19,856,000. Finally, Balyasny Asset Management L.P. grew its position in National Health Investors by 66.9% during the 2nd quarter. Balyasny Asset Management L.P. now owns 614,960 shares of the real estate investment trust’s stock worth $43,121,000 after purchasing an additional 246,486 shares during the last quarter. Hedge funds and other institutional investors own 62.51% of the company’s stock.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.